HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Severe neurological disabilities after complete remission of advanced malignant melanoma following fotemustine therapy in combination with total brain irradiation.

AuthorsC Gruss, A Geissler, B Schalke, M Landthaler, W Stolz
JournalMelanoma research (Melanoma Res) Vol. 12 Issue 4 Pg. 403-4 (Aug 2002) ISSN: 0960-8931 [Print] England
PMID12170192 (Publication Type: Case Reports, Letter)
Chemical References
  • Antineoplastic Agents, Alkylating
  • Nitrosourea Compounds
  • Organophosphorus Compounds
  • fotemustine
Topics
  • Antineoplastic Agents, Alkylating (adverse effects, therapeutic use)
  • Atrophy
  • Brain (drug effects, pathology, radiation effects)
  • Brain Damage, Chronic (chemically induced, etiology)
  • Brain Neoplasms (complications, drug therapy, radiotherapy, secondary)
  • Combined Modality Therapy
  • Cranial Irradiation (adverse effects)
  • Dementia (chemically induced, etiology)
  • Humans
  • Melanoma (complications, drug therapy, radiotherapy, secondary)
  • Middle Aged
  • Nitrosourea Compounds (adverse effects, therapeutic use)
  • Organophosphorus Compounds (adverse effects, therapeutic use)
  • Palliative Care
  • Quality of Life
  • Radiotherapy, High-Energy (adverse effects)
  • Remission Induction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: